Correlation Between Virpax Pharmaceuticals and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Reviva Pharmaceuticals.
Diversification Opportunities for Virpax Pharmaceuticals and Reviva Pharmaceuticals
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Virpax and Reviva is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Reviva Pharmaceuticals
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Reviva Pharmaceuticals. In addition to that, Virpax Pharmaceuticals is 1.06 times more volatile than Reviva Pharmaceuticals Holdings. It trades about -0.18 of its total potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.43 per unit of volatility. If you would invest 121.00 in Reviva Pharmaceuticals Holdings on September 15, 2024 and sell it today you would earn a total of 140.00 from holding Reviva Pharmaceuticals Holdings or generate 115.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Reviva Pharmaceuticals |
Virpax Pharmaceuticals and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Reviva Pharmaceuticals
The main advantage of trading using opposite Virpax Pharmaceuticals and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |